Lilly launches LillyDirect in Australia, shipping Mounjaro to patients
The direct-to-consumer channel bypasses community pharmacies, drawing objections from Australian doctors and pharmacists.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 2 09:58 ETSource: STAT
The wire
- 01Eli Lilly is bringing its LillyDirect direct-to-consumer platform to Australia, delivering the tirzepatide brand Mounjaro straight to patients' doors.
- 02The model cuts community pharmacies out of the dispensing chain for a high-volume incretin drug, a template other markets may follow.
- 03Local doctors and pharmacists have objected; how regulators and the supply chain respond in Australia is still unsettled.
From the source
Read at statnews.comSTAT+: Lilly bypasses Australian pharmacies with DTC model
Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and pharmacists aren’t thrilled.
